Biotech Firms Back Bill That Would Ease Financial Burden
San Francisco-area biotech companies are supporting a bill (AB 1370) that would increase from 10 years to 20 years the period of deductibility for net operating losses for life sciences companies. The Assembly unanimously passed the bill, and the legislation is expected to gain approval in the Senate.
- "Biotech Firms Back New Law Proposal" (Morrill, Contra Costa Times, 8/6).